Aurora Cannabis Inc. (the “Company” or “Aurora”) (ACB) (ACB) ( Frankfurt : 21P WKN: A1C4WM) and Radient Technologies Inc. (“Radient”) (TSX Venture: RTI OTCQX: RDDTF), announced these days that Aurora has taken delivery of Radient’s initially industrial batch of completed cannabis derivatives, from Radient’s proprietary extraction platform. With this initially batch, Radient has verified its enhanced capacity to generate cannabinoid derivatives at industrial scale, and will continue to scale up production at Radient’s cannabis facility in Edmonton , reaching an anticipated eventual annual throughput of roughly 300,000 kg of cannabis biomass at this single place.
The partnership amongst Radient and Aurora was established in 2017 following the completion of a Study Joint Venture that validated Radient’s MAPTM extraction technologies was capable of superior cannabinoid extraction at industrial scale. For Aurora, the partnership with Radient types an crucial element of its derivative solution method, supplying a higher return on the biomass allocated for extraction, favourable expense benefits, and considerably enhanced extraction capacity.
– Study the whole report at Yahoo News.